FDA NDC Directory · JSON-LD · Markdown

Fluzone Quadrivalent Northern Hemisphere

NDC 49281-926 · VACCINE · INJECTION, SUSPENSION

Generic nameINFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIG
Labeler / ManufacturerSanofi Pasteur Inc.
Marketing categoryBiologic License Application · App BLA103914
Dosage form / routeINJECTION, SUSPENSION · INTRAMUSCULAR
Active ingredientsINFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL)
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL)
INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL)
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) (15 ug/.5mL)
Marketing started20250701
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).